Novo Nordisk’s ousting of longtime CEO Lars Fruergaard Jørgensen bemused analysts, with many questioning the future of the Wegovy obesity drug maker.
Source link
Novo Nordisk's future in doubt after Wegovy maker's 'surprise' CEO ouster
The News of the Europe
